Last update Nov. 12, 2024
Compatible
We do not have alternatives for Idoxuridine since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Idoxuridine in other languages or writings:
Idoxuridine belongs to these groups or families:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Amamanta of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Idoxuridine is a pyrimidine nucleoside structurally related to thymidine with antiviral properties. It is used topically in the treatment of herpes simplex keratitis and cutaneous herpes simplex and herpes zoster infections. Topical ophthalmic or cutaneous application, 4 times a day for 4 days.
At the date of the last update, we found no published data on its excretion in breast milk.
The small dose and the almost nil plasma absorption rate of topical ophthalmic and dermatological preparations make it unlikely that any significant amount will pass into breast milk.
In addition, it is rapidly inactivated by deaminases or nucleotidases and is rapidly metabolized in the body to iodouracil, which is excreted in the urine. (Cecmed 2017)
Do not apply to the breast or clean well before breastfeeding.
WHO list of essential medicines: compatible with breastfeeding. (WHO-UNICEF 2002).